Chemical apparatus and process disinfecting – deodorizing – preser – Process disinfecting – preserving – deodorizing – or sterilizing – Process control in response to analysis
Reexamination Certificate
2001-07-13
2004-09-21
Jastrzab, Krisanne (Department: 1744)
Chemical apparatus and process disinfecting, deodorizing, preser
Process disinfecting, preserving, deodorizing, or sterilizing
Process control in response to analysis
C422S001000, C422S026000, C422S028000, C422S292000, C435S029000, C435S289100, C435S970000
Reexamination Certificate
active
06793880
ABSTRACT:
FIELD OF THE INVENTION
The present invention relates generally to monitoring the cleaning, disinfecting, and sterilizing of instruments and equipment. More particularly, the present invention relates to methods and devices for monitoring the efficacy of which medical devices are cleaned, disinfected, or sterilized.
BACKGROUND OF THE INVENTION
Known methods for disinfecting or sterilizing medical devices for re-use have historically used high pressure steam to render the surfaces of a medical device free of all forms of viable microorganisms (sterilization) or free from microorganisms except spore forming microorganisms (high level disinfection). In the last 40 years, medical devices have become more complex with respect to design and materials that are heat sensitive. Newer low temperature disinfection methods have accordingly been developed including ethylene oxide gas, vapor phase hydrogen peroxide, vapor phase peracetic acid and liquid disinfectants such as glutaraldehyde and peracetic acid solutions for reprocessing heat sensitive devices. However, many medical instruments are made of materials that may be damaged by exposure, especially repeated exposure, to high-pressure steam or gaseous disinfection procedures.
Devices that automatically clean and then disinfect medical and other equipment have been developed. Typically, these systems simply carry out a wash cycle for a preset duration. Cleaning is not always certain, especially when the water is not at the ideal temperature, the detergent is not at full strength, water pressure is abnormally low, the cleaning cycle is aborted due to an ineffective timing device, or if other error conditions are present.
One error condition is the failure to reduce the biological burden on incoming devices to an acceptable level. All health care reprocessing guidelines call for the precleaning of medical devices by a manual process that can reduce the bioburden level by 3 logs. Without a consistent manual precleaning process, any subsequent disinfection and sterilization is likely to fail. This is probably the greatest source of variability in the overall reprocessing sequence.
One particular class of medical devices, flexible endoscopes, has advanced the ability of medial practitioners for diagnosis but has also proved more difficult to adequately clean. Endoscopes are protectively encased bundles of flexible optical fibers used to transmit images to the operator at one end from otherwise inaccessible regions into which the opposite end of the instrument is inserted, so as to obtain a view of the structures surrounding such regions. Such an arrangement makes possible the visual examination, and even photographing, of structures surrounding cavities to which there is some external access, such access typically being a relatively small opening at some distance from the region of interest.
Endoscopes typically include means for allowing insertion of fluids into the region of interest and means for removal of tissue. Thus, in addition to the fiber optic bundle, there is usually provided a plurality of enclosed channels or passageways more or less paralleling the direction of the fiber optic bundle. These channels are also included within the enclosure that protects the fiber optic bundle. Specifically, such channels are typically provided to carry one or more of water, air, and carbon dioxide gas. A further channel is often provided to permit the extension therethrough of the instrumentation needed to conduct a biopsy of tissue in the region of interest. This latter channel may also be connected to a vacuum source as a means for obtaining fluid samples. This biopsy/suction source typically has a larger diameter than the other channels.
Because endoscopes are complex, highly instrumented medical devices, they are too costly to be disposable. Therefore, it is desirable to reuse such devices. Because they are exposed to bodily fluids and tissue, both internally and externally, it is necessary to clean these devices thoroughly before reuse.
Automated endoscopic reprocessors have been developed specifically to clean and disinfect flexible endoscopes to a level that mitigates the transmission of pathogenic organisms and disease between patients who are subject to an endoscopic procedure. U.S. Pat. No. 4,763,678, which is hereby incorporated by reference, discloses an exemplary endoscope reprocessor.
Automated endoscopic reprocessors (AERs) have significantly advanced the state of the art of reprocessing complex medical devices. Prior to the development of AER's, flexible endoscopies were cleaned and disinfected in an uncontrolled manual process of cleaning, disinfecting and rinsing in disinfectant. AER's provide an environment wherein the critical reprocessing parameters of liquid disinfectant use-life, rinse volumes, disinfectant contact time, disinfectant temperature and disinfectant volumes are controlled. The effectiveness of marketed disinfectants are carefully controlled by government regulatory agencies requiring scientific data related to the ability of the disinfectant to kill pathogenic under challenging conditions and related to the ability of AER's to deliver legally marketed disinfectants to the flexible endoscope being reprocessed.
U.S. Pat. No. 6,068,815 describes a chemical concentration detector using infrared light to determine concentration of the active agent. Monitoring of liquid chemical disinfection or sterilization can also be carried out by measuring the physical parameters of a reprocessing device as described in U.S. Pat. No. 6,156,267. When acceptable parameter levels have been met, the processed load is assumed to be disinfected or sterilized thus claiming to eliminate the need for biological indicators and chemical indicators or integrators. A drawback of this monitoring approach is that it fails to account for the variability associated with the type, resistance or amount of biological organisms that might be present in the medical device being reprocessed.
An additional method of monitoring the effectiveness of a particular disinfectant is through the use of biological indicators. Biological indicators are typically strips of paper or other porous media containing a controlled number of bacterial spores that provide a high level of challenge to the disinfectant process. Spores of
bacillus subtilis, bacillus circulans
and
bacillus stearotherophilus
have been used to monitor high-level disinfection processes including liquid disinfection and sterilization. A specific device to determine the effectiveness of a decontamination process with a self-contained biological indicator and a spore trapping microporous membrane is described in U.S. Pat. No. 5,736,355. While this device is useful for determining spore survival in the presence of a disinfectant, it does not address the problem of monitoring biological activity or the absence of biological activity within a thin, narrow endoscope lumen.
While some AER manufacturers have developed either chemical or biological indicators, as described above, to monitor the effectiveness of a particular high-level disinfection AER process or cycle, their use is problematic. Existing chemical or biological indicators for AER's do not take into account the challenge introduced by long, narrow lumens that provide an environment wherein microorganisms are difficult remove and can easily colonize the entire endoscope.
A relatively new problem in reprocessing of flexible endoscopes is related to advances in our understanding of a new class of materials called “biofilms”. Biofilms are microbiologically generated polysaccharide matrices that form when bacteria adhere to surfaces in aqueous environments and begin to excrete a slimy, glue like substance that can anchor them to all kinds of materials such as those found in medical devices and tissue. A biofilm can be formed by a single bacterial species, but more likely will consist of many species of bacteria, as well as fungi, algae, protozoa and inorganic products. Biofilms can form on any surface exposed to bacteri
Jastrzab Krisanne
Merchant & Gould P.C.
Minntech Corporation
LandOfFree
Apparatus and method for monitoring biofilm cleaning efficacy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Apparatus and method for monitoring biofilm cleaning efficacy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Apparatus and method for monitoring biofilm cleaning efficacy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3271394